Skip to main content
Have a personal or library account? Click to login
Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases Cover

Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases

Open Access
|Feb 2014

References

  1. ATSDR. (1995). Toxiological profi le for polycyclic aromatic hydrocarbons. Agency for Toxic Substances and Disease Registry. Atlanta, GA.
  2. ATSDR (2001). Toluene toxicity. Agency for Toxic Substances and Disease Registry. Atlanta, GA.
  3. Baker EL. (1988). Organic solvent neurotoxicity. Ann Rev Pub Health: 223-232.
  4. Baselt RC. (2000). Disposition of toxic drugs and chemicals in man, 5th ed. Chemical Toxicology Institute. Foster City, CA.
  5. Bendig P, Maier Lehnert K, Knapp H, Vetter W. (2012). Mass spectra of methyl esters of brominated fatty acids and their presence in soft drinks and cocktail syrups. Rapid Commun Mass Spectrum(9): 1083-1089.
  6. Bennett JW, Klich M. (2003). Mycotoxins. Clin Microbiol Rev(3): 497-516.
  7. Bernal C, Basilico MZ, Lombardo YB. (1986). Toxicological eff ects induced by the chronic intake of brominated vegetable oils. Arch Latinoam Nutr(3): 432-442.
  8. Bolanos JP, Moro MA, Lizasoain I, Almeida A. (2009). Mitochondria and reactive oxygen and nitrogen species in neurological disorders and strone: Therapeutic implications. Adv Drug Deliv Rev(14): 1299-1315.
  9. Blanc-Lapierre A, Bouvier G, Garrigou A, Canal-Raffi n M, Raherison C, Brouchard P, Baldi I. (2012). Chronic central nervous system eff ects of pesticides: state-of-the-art. Rev Epidemiol Sante Publique(5): 389-400.
  10. Brasel TL, Campbell AW, Demers RE, Ferguson BS, Fink J, Vojdani A, et al. (2004). Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys Chartum in indoor environments. Arch Environ Health(6): 317-323.
  11. Brender JD, Felkner M, Suarez L, Canfi eld MA, Henry JP. (2010). Maternal pesticide exposure and neural tube defects in Mexican Americans. Ann Epidemiol(1): 16-22.
  12. Brewer JH, Thrasher JD, Strauss DC, Madison RA, Hooper D. (2013). Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins: 605-615.
  13. Burbacher TM. (1993). Neurotoxic eff ects of gasoline and gasoline consituents. Env Health Perspect(Suppl 6): 133-141.
  14. Burstyn I, Kromhout H, Partanen T, Svane O, Langard S, Ahrens W, et al. (2005). Polycyclic aromatic hydrocarbons and fatal ischemic heart disease. Epidemiology(6): 744-750.
  15. Buters JT, Schober W, Gutermuth J, Jakob T, Aguilar-Pimentel A, Huss-Marp J, et al. (2007). Toxicity of parked motor vehicle indoor air. Environ Sci Technol(7): 2622-2629.
  16. Calderon-Garciduenas L, Solt AC, Henriquez-Roldan C, Torres-Jardon R, Nuse B, Herritt L, et al. (2008). Long-term air pollution exposure is associated with neuroinfl ammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafi ne particulate deposition, and accumulation of amyloid b-42 and a-synuclein in children and young adults. Toxicologic Pathology: 289-310.
  17. Carpenter DO. (2008). Environmental contaminants as risk factors for developing diabetes. Recv Environ Health(1): 59-74.
  18. Caudle WM, Guillot TS, Laxo C, Miller GW. (2012). Parkinson’s disease and the environment: Beyond pesticides. Neurotoxicology: 178-188.
  19. Chen CC, McCarl BA. (2001). An investigation of the relationship between pesticide usage and climate change. Climatic Change: 475-87.
  20. Chen R, Wilson K, Chen Y, Zhang D, Quin X, He M, et al. (2013). Association between environmental tobacco smoke exposure and dementia syndromes. Occup Environ Med: 63-79.
  21. Cheslack-Postava K, Rantakokko PV, Hinkka-Yi-Salomaki S, Surcel HM, McKeague IW, Kiviranta HA, et al. (2013). Maternal serum persistent organic pollutants in the Finnish Prenatal Study of Autism: A pilot study. Neurotoxicol Teratol: 1-5. doi: 10.1016/j.ntt.2013.04.001.
  22. Chia LG, Chu FL. (1984). Neurological studies on polychlorinated biphenyl (PCB)-poisoned patients. Prog Clin Biol Res: 117-26.
  23. Colborn T, Dumanoski D, Myers JP. (1997). Our stolen future. Penguin Books, New York.
  24. Colosio C, Tiramani M, Maroni M. (2003). Neurobehavioral eff ects of pesticides: state of the art. Neurotoxicology(4-5): 577-591.
  25. Conning DM, Phillips JC. (1986). Comparative metabolism of BHA, BHT and other phenolic antioxidants and its toxicological relevance. Food Chem Toxicol(10-11): 696-702.
  26. Costello S, Garcia E, Hammond SK, Eisen EA. (2013). Ischemic heart disease mortality and PM(3.5) in a cohort of autoworkers. Am J Ind Med(3): 317-325.
  27. Covaci A, de Boer J, Ryan JJ, Voorspoels S, Schepens P. (2002). Distribution of organobrominated and organochlorinated contaminants in Belgian human adipose tissue. Environ Res(3): 210-218.
  28. Culver AL, Ocknene IS, Balasubramanian R, Oldenski BC, Sepavich DM. (2012). Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative. Arch Int Med(2): 144-52.
  29. Dahlgren J, Takhar H, Anderson-Mahoney P, Kotlerman J, Tarr J, Warshaw R. (2007). Cluster of systemic lupus erythematosus (SLE) associated with an oil fi eld waste site: a cross sectional study. Environ Health: 8-23.
  30. Dardiotis E, Xiromerisiou G, Hadjichistodoulou C, Tsatsakis AM, Wilks MF, Hadjigeorgiou GM. (2013). The interplay between environmental and genetic factors in Parkinson’s disease susceptibility: the evidence for pesticides. Toxicology.: 17-23. doi: 10.1016/j.tox.2012.12.016.
  31. De Cock M, Maas YG, van de Bor M. (2012). Does perinatal exposure to endocrine disruptors induce autism spectrum and attention defi cit hyperactivity disorders? Review. Acta Paediatra(8): 811-818.
  32. Doi K, Uetsuka K. (2011). Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways. Int J Mol Sci(8): 5213-52037.
  33. Donn J. (2008). Philly fi nds 56 drugs in its water. Assoc Press.
  34. EIA (2013). U.S. Energy Information Administration. International energy outlook. July 25, 2013. http: //www.eia.gov/forcasts/ieo/ (last accessed 10/23/13) Escudar-Gilabert L, Villanueva-Camanas RM, Sagrado S, Medina-Hernandez MJ. (2009). Permeability and toxicological profi le estimation of organochlorine compounds by biopartitioning micellar chromatography. Biomed Chromatogr(4): 382-89.
  35. Farhat SC, Silva CA, Orione MA, Campos LM, Sallum AM, Braga AL. (2011). Air pollution in autoimmune rheumatic diseases: a review. Autoimmun Rev(1): 14-21.
  36. Faroon O, Jones D, de Rosa C. (2001). Eff ects of polychlorinated biphenyls on the nervous system. Toxicol Ind Health(7-8): 305-333.
  37. Filmore D. (2002). Breaching the blood-brain barrier. Mod Drug Discov(6): 22-27.
  38. Fitzgerald EF, Shrestha S, Gomez MI, McCaff rey RJ, Zimmerman EA, Kannan K, Hwang S. (2012). Polybrominated biphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and neuropsychological status among older adults in New York. Neurotoxicology(1): 8-15.
  39. Fleming L, Mann JB, Bean J, Briggle T, Sanchez-Ramos JR. (1994). Parkinson’s disease and brain levels of organochlorine pesticides. Ann Neurol(1): 100-103.
  40. Gallo MV, Schell LM, DeCaprio AP, Jacobs A. (2011). Levels of persistent organic pollutants and their predictors among young adults. Chemosphere(10): 1374-1382.
  41. Gamble JF. (2000). Low-level hydrocarbon solvent exposure and neurobehavioural eff ects. Occupat Med(2): 81-102.
  42. Gascon M, Verner MA, Guxens M, Grimalt JO, Forns J, Ibarluzea J, et al. (2013). Evaluating the neurotoxic eff ects of lactational exposure to persistent organic pollutants (POPs) in Spanish children. Neurotoxicology: 9-15. doi: 10.1016/j.neuro.2012.10.006.
  43. Grandjean P, Landrigan PJ. (2006). Developmental neurotoxicity of industrial chemicals. Lancet(9553): 2167-2178.
  44. Gregory AC 2nd, Shendell DG, Okosun IS, Gieseker KE. (2008). Multiple sclerosis disease distribution and potential impact of environmental air pollutants in Georgia. Sci Total Environ(1): 42-51.
  45. Gupta A, Agarwal R, Shukla GS. (1999). Functional impairment of blood-brain barrier following pesticide exposure during early development in rats. Hum Exp Toxicol(3): 174-79.
  46. Gupta SR, Palmer Cam Cure JK, Balos LL, Lincoff NS, Kline LB. (2011). Toluene optic neurotoxicity: nagnetic resonance imaging and pathologic features. Hum Pathol(2): 295-298.
  47. Ha, MH, Lee DH, Son HK, Park SK, Jacobs DR. (2009). Association between serum concentrations of persistent organic pollutants and prevalence of newly diagnosed hypertension: results from the National Health and Nutrition Examination Survey 1999-2002.
  48. Harley KG, Gunier RB, Kogut K, Johnson C, Bradman A, Calafat AM, Eskenazi B. (2013). Prenatal and early childhood bisphenol A concentrations and behavior in school-aged children. Environ Res.: 43-50. Doi: 10.1016/j.envres. 2013.06.004
  49. Hartz AMS, Bauer B, Block ML, Hong JS, Miller DS. (2008). Diesel exhaust particles induce oxidative stress, proinfl ammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. FASEB J: 2723-33.
  50. He C, Wang C, Zhou Y, Li J, Zuo Z. (2012). Embryonic exposure to benzo(a)pyrene infl uences neural development and function in rockfi sh (Sebastiscus marmoratus). Neurotoxicology(4): 758-762.
  51. Hertz-Picciotto, Park HY, Dostal M, Kocan A, Trnovec Y, et al. (2008). Pre-natal exposure to persistent and non-persistent organic compounds and eff ects on immune system development. Basic Clin Pharmacol Toxicol(2): 146-154.
  52. Humblet O, Birnbaum L, Rimm E, Mittleman MA, Hauser R. (2008). Dioxins and cardiovascular disease mortality. Environ Health Perspect(11): 1443-48.
  53. Iwaniuk AN, Koperski DT, Cheng KM, Elliot Je, Smith LK, Wilson LK, Wylie DR. (2006). The eff ects of environmental exposure to DDT on the brain of a songbird: changes in structures associated with mating and song. Behav Brain Res(1): 1-10.
  54. Jakovcevski M, Akbarian S. (2012). Epigenetic mechanisms in neurological disease. Nat Med(8): 1194-1204.
  55. Jurewicz J, Polanska K, Hanke W. (2013a). Exposure to widespread environmental toxicants and children’s cognitive development and behavioral problems. Int J Occup Med Environ Health(2): 185-204.
  56. Jurewicz J, Polanska K, Hanke W. (2013b). Chemical exposure early in life and the neyrodevelopment of children - an overview of current epidemiological evidence. Ann Agric Environ Med(3): 465-86.
  57. Kessler W, Numtip W, Volkel W, Seckin E, Csanady GA, Putz C, et al. (2012). Kinetics of di(ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in blood and of DEHP metabolites in urine of male volunteers after single ingestion of ring-diluted DEHP. Toxicol Appl Pharmacol(2): 284-291.
  58. Kim BH, Cho SC, Kim Y, Shin MS, Kim JW, Yang YH, et al. (2009). Phthalates exposure and attention-defi cit/hyperactivity disorder in school-age children. Biol Psychiatry(10): 958-963.
  59. Koch HM, Bolt HM, Angerer J. (2004). Di(2-ethylhexylphthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuteriumlabeled DEHP. Arch Toxicol(3): 123-130.
  60. Koch MW, Metz LM, Agrawal SM, Yong VW. (2013) Environmental factors and their regulation of immunity in multiple sclerosis. J Neurol Sci: 10-16.
  61. Kodavanti PRS. (2005). Neurotoxicity of persistent organic pollutants: possible mode(s) of action and further considerations. Dose-Response: 273-305.
  62. Krivoshto BA, Richards JR, Albertson TE, Derlet RW. (2008). The toxicity of diesel exhaust: Implications for primary care. J Am Bd Fam Med.(1): 55-62.
  63. La Merrill M, Cirillo PM, Terry MB, Krigbaum NY, Flom JD. (2013). Prenatal exposure to the pesticide DDT and hypertension diagnosed in women before age 50: A longitudinal birth control study. Environ Health Perspect(11): 594-599.
  64. Lammers JHCM, Muijser H, Owen DE, Kulig BM, McKee RH. (2011). Neurobehavioral eff ects of acute exposure to normal (n-) paraffi ns. Int J Toxicol(1): 47-58. Larsson M, Hagerhed-Engman L, Kolarik B, James P, Lundin F, Janson S, et al. (2010). PVC - as fl ooring material - and its association with incident asthma in s Swedish child cohort study. Indoor Air: 494-501.
  65. Le Cann P, Bonvallot N, Glorennec P, Deguen S, Goeury C, Le Bot B. (2011). Indoor environment and children’s health: recent developments in chemical, biological, physical and social aspects. Int J Hyg Environ Health(1): 1-18.
  66. Lee DH, Jacobs DR, Porta M. (2007). Association of serum concentrations of persistent organic pollutants with the prevalence of learning disability and attention defi cit disorder. J Epidemiol Community Health: 591-596.
  67. Lee DH, Steff es MW, Jacobs DR. (2007). Positive association of serum concentration of polychlorinated biphenyls or organochlroine pesticides with self-reported arthritis, especially rheumatoid type in women. Environ Health Perspect(6): 883-888.
  68. Lee DH, Jacobs DR, Kocher T. (2008a). Associations of serum concentrations of persistent organic pollutants with the prevalence of periodontal disease and subpopulations of white blood cells. . Environ Health Perspect(11): 1558-1562.
  69. Lee DH, Jacobs DR Jr, Steff es M. (2008b). Association of organochlorine pesticides with peripheral neuropathy in patients with diabetes or impaired fasting glucose. Diabetes(11): 3108-3111.
  70. Lee DH, Steff es MW, Sjoden A, Jones RS, Needham LL., et al. (2010). Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study. Environ Health Perspect(9): 1235-1242.
  71. Li Z, Romanoff L, Bartell S, Pittman EN, Trinidad DA, McLean M, et al. (2012). Excretion profi les and half-lives of ten urinary polycyclic aromatic hydrocarbon metabolites after dietary exposure. Chem Res Toxicol(7): 1452-1461.
  72. Lind PM, van Bavel B, Salihovic S, Lind L. (2012). Circulating levels of persistent organic pollutants (POPs) and carotid atherosclerosis in the elderly. Environ Health Perspect(1): 38-43.
  73. Lind PM, Lind L. (2012). Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease? J Intern Med(6): 537-553
  74. Lochhead JL, McCaff rey G, Quigley CE, Finch J, DeMarco KM, Nametz N, Davis TP. (2010). Oxidative stress increases blood-brain barrier permeability and induces alterations in occluding during hypoxia-reoxygenation. J Cerebral Blood Flow Metab: 1625-1636.
  75. Logroscino G, Traynor BJ, Hardiman O, Chio’ A, Couratier P, Mitchell JD, et al. (2008). Desciptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry(1): 6-11.
  76. Maruff P, Burns CB, Tyler P, Currie BJ, Currie J. (1998). Nerological and cognitive abnormalities associated with chronic petrol sniffi ng. Brain: 1903-1917.
  77. Mates JM, Segura JA, Alonso FJ, Marquez J. (2010). Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms. Free Rad Biol Med(9): 1328-41.
  78. Mayeux R, Stern Y. (2012). Epidemiology of Alzheimer’s disease. Cold Spring Harb Perspect Med(8). doi: 10.1101/cshperspect.a006239.
  79. McCanlies EC, Fekedulegn D, Mnatsakanova A, Burchfi el CM, Sanderson WT, Charles LE, Herts-Picciotto I. (2012). Parental occupational exposures and autism spectrum disorder. J Autism Dev Discord(11): 2323-2334.
  80. Michalek JE, Akhtar FZ, Arezzo JC, Garabrant DH, Albers JW. (2001). Serum dioxin and peripheral neuropathy in veterans of Operation Ranch Hand. Neurotoxicology(4): 479-90.
  81. Moldes-Anaya A, Rundberget T, Faeste CK, Eriksen GS, Berhoft A. (2012). Neurotoxicity of penecillium crustosum secondary metablolites: tremorgenic activity of orally administered penitrem A and thomitrem A and E in mice. Toxicon(8): 1428-1435.
  82. Moses V, Peter JV. (2010). Acute intentional toxicity: endosulfan and other organochlorines. Clin Toxicol (Phila)(6): 539-544.
  83. Mostafalou S, Abdollahi M. (2013). Pesticides and human chronic diseases: evidences, mechanisms, and perspectives. Toxicol Appl Pharmacol(2): 157-77.
  84. Mullerova D, Kopecky J. (2007). White adipose tissue: storage and eff ector site for environmental pollutants. Physiol Res(4): 375-381.
  85. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012). Disabilityadjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet: 2197-2223.
  86. Mustafi c H, Jabre P, Caussin C, Murad MH, Escolano S, et al. (2012). Main air pollutant and myocardial infarction: a systematic review and meta-analysis. JAMA(7): 713-721.
  87. Nishijo M, Tawara K, Nakagawa H, Honda R, Kido T, et al. (2008). 2,3,7,8-tetrachlorodibenzo- p-dioxin in maternal breast milk and newborn head circumference. J Expo Sci Environ Epidemiol(3): 246-251.
  88. Noakes PS, TaylorP, Wilkinson S, Prescott SL. (2006). The relationship between persistent organic pollutants in maternal and neonatal tissues and immune responses to allergens: a novel expoloratory study. Chemosphere(8): 1304-1311.
  89. Pan Y, Johnson AR, Rea WJ. (1987). Aliphatic hydrocarbon solvents in chemically sensitive patients. Clin Ecol(3): 126-131.
  90. Pardridge WM. (2012). Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab(11): 1959-72.
  91. Parron T, Requena M, Hernandez AF, Alarcon R. (2011). Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol Appl Pharmachol(3): 379-385.
  92. Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF. (2009). Getting into the brain: approaches to enhance drug delivery. CNS Drugs(1): 35-58.
  93. Patri M, Padmini A, Babu PP. (2009). Polycyclic aromatic hydrocarbons in air and their neurotoxic potency in association with oxidative stress: a brief perspective. Ann Neurosci(1): 1-9.
  94. Patrick L. (2009). Thyroid disruption: mechanisms and clinical implications in human health. Alt Med Rev(4): 326-346.
  95. Peraica M, Radic B, Pavlovic M. (1999). Toxic eff ects of mycotoxins in humans. Bull World Health Org(7): 754-766.
  96. Pessah IN, Seegal RF, Lein PJ, LaSalle J, Yee BK, Van De Water J, Berman RF. (2008). Immunologic and neurodevelopmental susceptibilities of autism. Neurotoxicology(3): 531-544.
  97. Pestka JJ, Yike I, Dearborn DG, Ward MD, Harkema JR. (2008). Stachybotrys, trichlothecene mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol Sci(1): 4-26.
  98. Polanska K, Jurewicz J, Hanke W. (2013). Review of current evidence on the impact of pesticides, polychlorinated biphenyls and selected metals on attention defi cit / hyperactivity disorder in children. Int J Occupat Med Environ Health(1): 16-38.
  99. Quaak I, Brouns MR, Van de Bor M. (2013). The dynamics of autism spectrum disorders: How neurotoxic compounds and neurotransmitters interact. Int J Environ Res Pub Health: 3384-3408.
  100. Queckenberg C, Meins J, Wachall B, Doroshyenko O, Tomalik-Scharte D, Bastian B, et al. (2010). Absorption, pharmacokinetics, and safety of triclosan after dermal administration. Antimicrobial Agents and Chemotherapy(1): 570-572.
  101. Qiu C, cheng S, Xia Y, Peng B, Tang Q, Tu B. (2011). Eff ects of subchronic benzo(a)pyrene exposure on neurotransmitter receptor gene expression in the rat hippocampus related with spatial learning and memory change. Toxicology(2-3): 83-90.
  102. Ren A, Qiu X, Jin J, Li Z, Ma J, Zhiwen L, et al. (2011). Association of selected persistent organic pollutants in the placenta with the risk of neural tube defects. Proc Natl Acad Sci USA(31): 12770-12778.
  103. Reddy L, Bhoola K. (2010). Ochratoxins - food contaminants: impacts on human health. Toxins: 771-779.
  104. Roberts AL, Lyall K, Hart JE, Laden F, Just AC, Bobb JF, et al. (2013). Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses’ Health Study II participants. (2013): Environ Health Perspect(8): 978-984.
  105. Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. (2007). Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect(10): 1482-1489.
  106. Roze E, Meijer L, Bakker A, Van Braechel KN, Sauer PJ, Bos AF. (2009). Prenatal exposure to organohalogens, including brominated fl ame retardants, infl uences motor, cognitive, and behavioral performance at school age. 2009. Environ Health Perspect(12): 1953-1958.
  107. Sagiv SK, Thurston SW, Bellinger DC, Altschul LM, Korrick SA. (2012). Neuropsychological measures of attention and impulse control among 8-year old children exposed prenatally to organoclorines. Environ Health Perspect(6): 904-909.
  108. Sagiv SK, Thurston SW, Bellinger DC, Tolbert PE, Altschul LM, Korrick SA. (2010). Prenatal organochlorine exposure and behaviors associated with attention defi cit hyperactivity disorder in school-aged children. Am J Epidemiol: 593-601.
  109. Sandborg-Englund G, Adolfsson-Erici M, Odham G, Ekstrand J. (2006). J Toxicol Environ Health A(20): 1861-1873. Seelbach M, Chen L, Powell A, Choi YJ, Zhang B, Hennig B, Toborek M. (2010). Polychlorinated biphenyls disrupt blood-brain barrier integrity and promote brain metastasis formation. Environ Health Perspect(4): 479-84.
  110. Seelig A, Gottschlich R, Devant RM. (1994). A method to determine the ability of drugs to diff use through the blood-brain barrier. Proc Natl Acad Sci USA: 68-72.
  111. Sendur OF, Turan Y, Bal S, Gurgan A. (2009). Toxic neuropathy due to N_hexane: report of three cases. Inhal Toxicol(3): 210-214.
  112. Sergeev AV, Carpenter DO. (2011). Geospatial patterns of hospitalization rates for stroke with comorbid hypertension in relation to environmental sources of persistent organic pollutants: results from a 12-year populationbased study. Environ Sci Pollut Res Int(4): 576-585.
  113. Shankar A, Teppala S. (2012). Urinary bisphenol a and hypertension in a multiethnic sample of U.S. adults. J Environ Public Health: 481641. doi: 10.1155/2012/897134.
  114. Snyder MJ, Mulder EP. (2001). Environmental endocrine disruption in decapod crustacean larvae: hormone titers, cytochrome P 450, and stress protein responses to heptachlor exposure. Aquat Toxicol(3-4): 177-190.
  115. Sozeri B, Gulez N, Aksu G, Kutukculer N, Akalin T, Kandiloglu G. (2012). Pesticide- induced scleroderma and early intensive immunosuppressive treatment. Arch Environ & Occupat Health(1): 43-47.
  116. Stahlhut RW, Welshons WV, Swan SH. (2009). Bisphenol A data in NHANES suggest longer thanexpected half-life, substantial nonfood exposure, or both. Environ Health Perspect(5): 784-789.
  117. Steenland K, Wesseling C, Roman N, Quiros I, Juncos JL. (2013). Occupational pesticide exposure and screening tests for neurodegenerative disease among an elderly population in Costa Rica. Environ Res: 96-101. Doi. org/10.1016/l.envres.2012.08.014.
  118. Sun Y, Nakashima MN, Takahashi M, Kuroda N, Nakashima K. (2002). Determination of bisphenol A in rat brain by microdialysis and column switching high-performance liquid chromatography with fl uorescence detection. Biomed Chromatogr(5): 319-26.
  119. Surak JG, Bradley RL Jr, Branen AL, Maurer AJ, Ribelin WE. (1977). Butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) eff ects on serum and liver lipid levels in Gallus domesticus. Poult Sci(3): 747-753.
  120. Sweeney MH, Fingerhut MA, Arezzo JC, Hornung RW, Connally LB. (1993). Peripheral neuropathy after occupational exposure to 2,3,7,8-tetrachlorodibenzo- dioxin (TCDD). Am J Ind Med(6): 845-58.
  121. Szychowski KA, Wojtowicz AK. (2013). Components of plastic disrupt the function of the nervous system. Postepy HIg Med Dpsw: 499-506.
  122. Thomke F, Jung D, Besser R, Roder R, Konietzko J, Hopf HC. (1999). Increased risk of sensory neuropathy in workers with chloracne after exposure to 2,3,7,8-polychlorinated dioxins and furans. Acta Neuro Scand(1): 1-5.
  123. Toren K, Bergdahl A, Nilsson T, Jarvholm B. (2007). Occupational exposure to particulate air pollution and mortality dye to ischaemic heart disease and cerebrovascular disease. Occup Environ Med: 515-519.
  124. Tryphonas H. (1998). The impact of PCBs and dioxins on children’s health: immunological considerations. Can J Pub Health(May-June): 554-557.
  125. Verhagen H, Beckers HH, Comuth PA, Maas LM, ten Hoor F, Henderson PT, Kleinjans JC. (1989). Disposition of single oral doses of butylated hydroxytoluene in man and rat. Food Chem Toxicol 27(12): 765-772.
  126. Uccelli R, Binazzi A, Altavista P, Belli S, Comba P, Mastrantonio M, Vanacore N. (2007). Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol(11): 781-790.
  127. Urdinguio RG, Sanchez-Mut JV, Esteller M. (2009). Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. The Lancet Nuerology(11): 1056-1072.
  128. Uttara B, Singh AV, Zamboni P, Mahajan RT. (2009). Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol(1): 65-74.
  129. Verhangen H, Beckers HH, Comuth PA Maas LM, ten Hoor F, et al. (1989). Dispositions of single oral doses of butylated hydroxytoluene in man and rat. Food Chem Toxicol(12): 765-772.
  130. Viberg H, Fredriksson A, Buratovic S, Eriksson P. (2011). Dose-dependent behavioral disturbances a ft er a single neonatal Bisphenol A dose. Toxicology(2-3): 187-194.
  131. Viaene MK. (2002). Overview of the neurotoxic eff ects in solvent-exposed workers. Arch Pub Health: 217-232.
  132. Viberg H, Lee I. (2012). A single exposure to bisphenol A alters the levels of important neuroproteins in adult male and female mice. Neurotoxicology(5): 1390-1395.
  133. Vincenti M, Bottecchi I, Fan A, Finkelstein Y, Mandrioli J. (2012). Are Environmental exposures to selenium, heavy metals and pesticides risk factors for amyotrophic lateral sclerosis? Rev Environ Health(1): 19-41.
  134. Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnel R. (2011). Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect(6): 873-877.
  135. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, et al. (2012). Years lived with disability (YLDs) for 1160 sequalae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet: 2163-96.
  136. Wang A, Costello S, Cockburn N, Zhang X, Bronstein J, Ritz B. (2011). Parkinson’s disease risk form ambient exposure to pesticides. Eur J Epidemiol(7): 547-555.
  137. Weintraub E, Gandhi D, Robinson C. (2000). Medical complications due to mothball abuse. South Med J(4): 427-429.
  138. Weiss B. (2012). The intersection of neurotoxicology and endocrine disruption. Neurotoxicology(6): 1410-19.
  139. Weitzman M, Govil N, Liu YH, Lalwani AK. (2013). Maternal prenatal smoking and hearing loss among adolescents. JAMA Otolaryngol Head Neck Surg(7): 669-677.
  140. White RF, Proctor SP. (1997). Solvents and neurotoxicity. Occup Med: 1239-1243.
  141. Whane TF. (2011). Atherosclerosis: current status of prevention and treatment. Int J Angiology(4): 213-222.
  142. Widholm JJ, Seo BW, Strupp BJ, Seegal RF, Schantz SL. (2003). Eff ects of perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on spatial and visual reversal learning in rats. Neurotoxicol Teratol(4): 459-71.
  143. WHO. (2006). Almost a quarter of all disease caused by environmental exposure.
  144. World Health Organization, Geneva, Switzerland. Available from http: //www.who.int/mediacentre/news/releases/2006/pr32/index.hmtl (Accessed September 8, 2013).
  145. Wichmann J, Folke F, Torp-Pedersen C, Lippert F, Ketzel M, et al. (2013). Outof- hospital cardiac arrests and outdoor air pollution exposure in Copenhagen, Denmark. PLoS One(1): e53684.
  146. Winneke G. (2011). Developmental aspects of environmental neurotoxicology: lessons from lead and polychlorinated biphenyls. J Neurol Sci(1-2): 9-15.
  147. Wu S, Deng F, Liu Y, Shima M, Niu J, et al. (2012). Temperature, traffi c-related air pollution, and heart variability in a panel of healthy adults. Environ Res: 82-89.
  148. Yokota S, Ohara N, Kabayashi T. (2008). The eff ects of organic extract or diesel exhaust particles on ischemia/reperfusion-related arrhythmia and on pulmonary fuction. J Toxicol Sci(1): 1-10.
  149. Yolton K, Xu Y, Strauss D, Altaye M, Calafat AM, Khoury J. (2011). Prenatal exposure to bisphenol A and phthalates and infant neurobehavior. Neruotoxicol Teratol(5): 558-566.
  150. Yu GW, Laseter J, Mylander C. (2011). Persistent organic pollutants in serum and several diff erent fat compartments in humans. J Environ Public Health: 417980. doi: 101155/2011/417980.
  151. Zaganas I, Kapetanaki S, Mastorodemos V, Knavouras K, Colosio C, Wilks MF, Tsatsakis AM. (2013). Linking pesticide exposure and dementia: What is the evidence? Toxicology: 3-11. Doi: 10.1016/j.tox.2013.02.002.
  152. Zeliger HI. (2003). Toxic eff ects of chemical mixtures. Arch Environ Health(1): 23-29.
  153. Zeliger HI. (2004). Unexplained cancer clusters: common threads. Arch Environ Health(4): 172-176.
  154. Zeliger HI. (2011). Human toxicology of chemical mixtures, 2nd ed. Elsevier, London.
  155. Zeliger HI. (2012). Statin use and risk of diabetes. Arch Int Med(11): 896-897.
  156. Zeliger HI, Pan Y, Rea WJ. (2012). Predicting co-morbidities in chemically sensitive individuals from exhaled breath analysis. Interdiscip Toxicol(3): 123-126.
  157. Zeliger HI. (2013a). Lipophilic chemical exposure as a cause of cardiovascular disease. Interdiscip Toxicol(2): 55-62.
  158. Zeliger HI. (2013b). Lipophilic chemical exposure as a cause of type 2 diabetes (T2D). Rev Environ Health(1): 9-20.
DOI: https://doi.org/10.2478/intox-2013-0018 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 103 - 110
Published on: Feb 27, 2014
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2014 Harold I. Zeliger, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.